Emergency pharmacy order
Ended Awarded
- Contract number
- 36C26024F0075
- Awardee
-
Aimmune Therapeutics, Inc. UEI E3ULPC7MFBK9
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,100
Award facts
- Contract value 100% obligated
- $13,099.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Brisbane, CA 94005, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for an "EMERGENCY PHARMACY ORDER" made by the Veterans Integrated Service Network 20 (VISN 20), a component of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Aimmune Therapeutics, Inc., a biopharmaceutical company specializing in developing treatments for food allergies, particularly peanut allergies. Aimmune Therapeutics' primary product offered under this contract is Palforzia, an oral immunotherapy indicated to reduce the severity of allergic reactions to peanuts in children and adolescents.
The contract is a firm-fixed price delivery order with a ceiling value of $13,099.50 and an ultimate completion date of November 30, 2023. It was awarded under Aimmune Therapeutics' Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs. The company also holds two Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center specifically for Palforzia, with the most recent BPA having a ceiling value of $500,000 and running through April 14, 2025. These contract vehicles demonstrate the VA's commitment to ensuring consistent access to Aimmune's allergy treatments for veterans through various VISN and VA medical center locations.
Quick answers
Who was awarded contract 36C26024F0075?
36C26024F0075 was awarded to Aimmune Therapeutics, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 7, 2023.
How much is contract 36C26024F0075 worth?
The government has obligated $13,100 on 36C26024F0075.
Is contract 36C26024F0075 an order under another contract?
Yes. 36C26024F0075 is a delivery order under 36F79721D0150, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0075 competed?
The extent of competition for 36C26024F0075 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award